Use of aripiprazole for delirium in the elderly: a short review.

Abstract

The effects and tolerability of antipsychotics in delirium treatment remain controversial. Compared to other antipsychotics, aripiprazole differs in pharmacological activity because it exerts its effect as a dopamine D2 partial agonist. The guidelines of the American Psychiatric Association rank aripiprazole highly among antipsychotics with regard to safety, and this drug is likely to be useful for delirium treatment. Here, we reviewed the efficacy and safety of aripiprazole for delirium. The results of our literature review on the efficacy and safety of delirium treatments suggest that aripiprazole is an effective treatment option for delirium in the elderly. Aripiprazole is as effective as other antipsychotics in improving delirium symptoms, and it is safer because it is less likely to cause extrapyramidal symptoms, excessive sedation, and weight gain. However, these findings are based on only a few clinical studies of elderly patients with delirium. Therefore, further investigations are necessary.

• Authors: Eiji Kirino
• Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society (Psychogeriatrics) Vol. 15 Issue 1 Pg. 75-84 (Mar 2015) ISSN: 1479-8301 [Electronic] England
• PMID: 25514894 (Publication Type: Comparative Study, Journal Article, Review)
• Copyright: © 2014 The Author. Psychogeriatrics © 2014 Japanese Psychogeriatric Society.

Chemical References

• Antipsychotic Agents
• Receptor, Serotonin, 5-HT2A
• Receptors, Dopamine D2
• Receptor, Serotonin, 5-HT1A
• Aripiprazole

Topics

• Aged
• Antipsychotic Agents (adverse effects, therapeutic use)
• Aripiprazole (adverse effects, therapeutic use)
• Delirium (diagnosis, drug therapy)
• Humans
• Receptor, Serotonin, 5-HT1A (drug effects)
• Receptor, Serotonin, 5-HT2A (drug effects)
• Receptors, Dopamine D2 (agonists)
• Treatment Outcome